Overview
Alleviate provides at-home, injury-specific treatment systems for musculoskeletal pain by selling devices like a re-engineered brace and arch massager that pair with an app-guided program. The app directs daily 10–15 minute routines, including soft tissue work, load management, and progressive strengthening, to mimic physical therapy outside a clinic. It differentiates itself through a clinician-led origin and a direct-to-consumer model, combining hands-on tools with structured rehabilitation for scalable, non-invasive care. The goal is to make PT-like treatment more accessible and help tens of thousands of people recover from chronic injuries without in-person visits.
Work here?Claim your company
Simplify's take
What believers are saying
- 2026 product pages show HSA/FSA eligibility and 30-day returns, easing purchase friction.
- The company reports 30,000+ customers and 2025 gross margins around 68%.
- Updated November 2026 pages highlight expanded plantar fasciitis bundles and stronger cross-sell packaging.
What critics are saying
- 2026 exec summary shows $741k revenue and negative EBITDA, limiting reinvestment capacity.
- The company seeks $1.9 million for physician-channel scale, signaling dependence on outside capital.
- Amazon, generic braces, and telehealth PT apps compress margins and erase Alleviate's DTC advantage.
What makes Alleviate unique
- Luke Ferdinands and Rick Rafferty combine clinician expertise with patient-first product design.
- Alleviate sells injury-specific home systems bundling brace, arch massager, and guided app programs.
- The company targets common chronic soft-tissue injuries with a three-part PT-like recovery method.
Help us improve and share your feedback! Did you find this helpful?